Peptide Adsorption to Glass vs Plastic — and the BSA Carrier Fix

A peptide solution can read as almost blank on an assay while the vial in front of you looks entirely normal. The powder went in. The buffer went in. The liquid is clear. Most of the material simply never reached the measurement, because it's sitting on the inside wall of the container. Everything discussed here concerns research-grade material handled in a laboratory setting. These compounds are for research use only and are not intended for human or animal consumption of any kind.

Adsorption to the vessel is one of the most common invisible sources of error in low-concentration peptide work, and it earns attention because it isn't a quality problem with the peptide. It's a surface problem with the container. Below we cover what drives the loss, why borosilicate glass and polypropylene fail on different peptides, how large the loss gets in published measurements, and where bovine serum albumin — the classic carrier-protein fix — genuinely helps.

Why Peptides Disappear From Solution: The Sample You Never Measured

A container wall is not a neutral boundary. It's a competing surface with enormous area relative to the volume it holds, and a dilute peptide is constantly choosing between staying solvated and binding to it.

A Wall Is a Competing Surface

Peptides are chemically well suited to sticking. Many research-grade sequences are amphipathic, carrying charged residues on one face and nonpolar residues on the other, which gives them a plausible binding mode on almost any material. A hydrophilic surface engages the charged face; a greasy surface engages the nonpolar one. That contest between water and the wall also governs whether a peptide dissolves cleanly, which is why getting a peptide into solution in the first place and keeping it there are two views of one problem.

The Loss Is Silent

What makes this failure mode dangerous is that nothing looks wrong. The solution stays clear, and the label still says the nominal concentration. Instead the error surfaces indirectly — a curve sitting lower than expected, a signal that never appears at the bottom of a dilution series, poor agreement between vessels that should have held identical material. Those symptoms get blamed on the compound or the assay when the culprit is the tube.

Glass and Plastic Grab Peptides in Two Different Ways

Here's the point that undermines most rules of thumb. Glass and plastic differ less in how much they bind than in which peptides they bind, and the two mechanisms are chemically distinct.

Borosilicate Glass and Residual Silanol Groups

Glass surfaces carry residual silanol groups, and published handling guidance notes that basic amino acids can form electrostatic interactions with residual silanol groups on glass vials. The consequence is straightforward. Cationic peptides — anything rich in lysine, arginine or histidine — are the vulnerable class on glass. The wall is mildly negative, the peptide is positive, and the two find each other.

Polypropylene and Hydrophobic Contact

Plastic fails the opposite population. Nonpolar amino acids, per that same guidance, interact with the hydrophobic surface of polypropylene vials. Greasy sequences bind plastic for the same reason they linger on a reversed-phase column, which makes peptide hydrophobicity and how RP-HPLC reads it a useful predictor of storage behaviour. A late-eluting peptide is telling you about its affinity for nonpolar surfaces generally, not just about the column.

Neither Material Is Universally Safer

It's tempting to conclude that plastic simply wins. One comparison found a single unstable peptide in polypropylene vials against 13 and 14 in non-deactivated and deactivated glass respectively. But that result is population-dependent, and other work pushes the opposite way: in intact-peptide mass spectrometry, deactivated glass showed little or no recovery for hydrophobic peptides. Silanization, the standard fix for the glass problem, does nothing for a sequence whose issue was never electrostatic. Match the container to the sequence, not to a general rule.

How Much Peptide Actually Disappears

The magnitude here is the part that surprises people. This is not a rounding error.

The Headline Numbers

Analytical HPLC work on three cationic peptides — mastoparan X, melittin and magainin 2 — found that at 1 micromolar in 220 microlitre volumes, only 10 to 20 percent of peptide was recovered from borosilicate glass vials. Polypropylene tubes did comparably badly on that cationic set, and quartz cuvettes, widely assumed inert, returned 50 percent or less for all three.

Move the solution around and it gets worse. Transferred successively through four fresh glass vials or four polypropylene tubes, recovery fell close to zero. Every transfer offers an unsaturated surface, and the peptide obliges.

Total Loss Is a Real Outcome

In LC-MS quantitation work, the Vn96 peptide at 10 picograms per microlitre produced no signal at all in regular vials — the authors concluded that all of the analyte was lost to adsorption. Not diminished. Gone, from an ordinary vial of the kind sitting in every laboratory drawer.

Why There Is No Single Number

None of this converts to a universal correction factor, and published guidance declines to offer one. Loss is sequence- and concentration-dependent, so adsorption is a variable you control rather than a constant you subtract.

The Geometry Problem: Volume, Transfers and Cold Storage

Before reaching for any chemical fix, notice how much of the loss is set by physical choices that cost nothing to change.

Surface-Area-to-Volume Ratio Sets the Scale

The same peptide recovers far better from a 2 millilitre volume than from a 220 microlitre one, because the wall area per unit of solution is much smaller. Fewer transfers help for the same reason — every new vessel is a fresh surface waiting to be saturated.

Tube Brand Is a Variable, Not a Detail

A systematic comparison of low-binding and standard microtubes from six manufacturers found that recovery of a 100 nanogram protein load ranged from 95.8 percent in the best tube down to 18.4 percent in the worst. The downstream cost is measurable: that same study recorded 8,639 peptide-spectrum matches from a cell digest prepared in the best tube against 4,960 from a standard one. Nearly half the identifications, lost to plastic.

Cold Storage Can Make Things Worse

Refrigeration is not automatically protective. One tube in that comparison recovered 99.9 percent at 37 °C but only 22.6 percent at 4 °C, and four of the tested microtubes lost significantly more protein at the colder temperature. Cold storage in the wrong vessel is its own loss mechanism, compounding with the separate chemistry of what freeze-thaw actually does to a peptide.

Concentration Is a Defence in Its Own Right

Because adsorption saturates the available binding sites, concentrated stocks lose proportionally less. In one test, mixtures held at 1000 femtomoles per microlitre showed no measurable signal decay, while the same mixtures at 200 femtomoles per microlitre showed decay in nine peptides. Hence the standing recommendation: keep stocks at 0.5 to 2 nanomoles per microlitre and dilute immediately before use.

The BSA Carrier Fix: How a Sacrificial Protein Works

When physical measures aren't enough, the standard answer is to give the wall something else to bind. Bovine serum albumin is cheap, abundant and well characterised, which is why it became the default.

Competitive Occupation, Not a Sealed Film

The common mental picture — BSA forming an impermeable coat over the glass — isn't quite what happens. Surface studies show that the blocking action of adsorbed BSA layers involves competitive adsorption and desorption. Albumin and the incoming analyte exchange continuously at the surface. Blocking works because BSA sits in large molar excess and reaches the open sites first.

Partial Coverage Is Enough

That dynamic picture explains an otherwise odd finding. A BSA layer covering only 35 percent of a close-packed monolayer delivered 90 to 100 percent blocking efficiency on a hydrophobic surface and 68 to 100 percent on a hydrophilic one, measured against nonspecific adsorption of concanavalin A, immunoglobulin G and staphylococcal protein A. Effective layers formed from a 1 mg/mL solution with 30 minutes of contact. Note the asymmetry, though: blocking is stronger on plastic than on hydrophilic glass, where residual silanol sites stay accessible even under an albumin layer.

The Same Idea, Generalised

Albumin is one instance of a broader strategy, and analytical work often picks a different competitor precisely so it won't interfere. In intact-protein LC-MS, apomyoglobin produced a linear calibration curve only once carbonic anhydrase was added at 10 micrograms per millilitre as an adsorption competitor, chosen because it does not co-elute with the analyte. The authors also saw a conditioning effect — the protective benefit persisted in later samples after the competitor had been removed, consistent with the carrier having durably occupied the reactive sites on the wall. Anyone who has run ELISA, where blocking buffers are routine, has already used this chemistry; the tube is a plate with a different shape.

Where BSA Falls Short, and What Labs Use Instead

The plain answer to "why not always add albumin" is that a large excess of a foreign protein is often the last thing an experiment can tolerate.

The Interference Problem

Mass spectrometry, protein quantitation and single-molecule imaging all degrade badly when albumin dominates the sample. Published guidance for mass-spectrometry assays states flatly that there is currently no consensus on the best carrier molecules or the optimum concentration. For the most surface-sensitive work the ceiling is explicit: a protocol for surface passivation in single-molecule protein studies judges BSA treatment adequate for nucleic-acid experiments but not high enough in degree for protein studies, favouring covalent polyethylene glycol coating instead.

Non-Protein Alternatives

Several approaches sidestep interference entirely. Low-bind tubes using co-polymer surface chemistry were the top performers in the microtube comparison above. Lipid vesicles work as a competing surface: 1 millimolar POPC/POPG at a 3:1 ratio blocked adsorption of all three cationic peptides on both glass and polypropylene. Organic solvent additives work too — acetonitrile at 5 to 30 percent cut orexin carry-over from 20–50 percent down to 1–2 percent and improved detection limits by 1.4- to 60-fold. Polyethyleneimine surface modification raised mouse beta-endorphin recovery 32-fold in the same study.

The Loss Is Spread Across the Whole Fluid Path

One last correction to the mental model. That neuropeptide work traced losses to tubing, dialysis membranes and the sample-loading valve, not only to the storage vial, with carry-over still visible after three or four blank runs. Fixing the tube while ignoring everything downstream solves part of the problem and hides the rest.

Frequently Asked Questions

Does peptide stick more to glass or to plastic?

Neither material wins outright, because they fail on different peptides. Borosilicate glass carries residual silanol groups that hold positively charged, basic residues through electrostatic attraction, so cationic peptides suffer most there. Polypropylene presents a hydrophobic surface that holds nonpolar residues, so hydrophobic peptides suffer most there. One handling study found a single unstable peptide in polypropylene vials against 13 and 14 in untreated and deactivated glass, but other work reports that deactivated glass gives little or no recovery for hydrophobic peptides specifically. The right container depends on the sequence.

How much peptide can actually be lost to a container wall?

Enough to invalidate a measurement. Analytical HPLC work on three cationic peptides recovered only 10 to 20 percent of material from borosilicate glass vials at 1 micromolar in a 220 microlitre volume. When the same solutions were moved through four fresh vessels in sequence, recovery fell to near zero. In a separate microtube comparison, recovery of a 100 nanogram protein load ranged from 95.8 percent in the best tube down to 18.4 percent in the worst. The loss is largest at low concentrations and in small volumes.

How does BSA stop other proteins from sticking?

Bovine serum albumin works as a sacrificial competitor rather than a sealed barrier. Added in large molar excess, it occupies binding sites on the vessel wall faster than the peptide of interest can reach them. Surface studies show the layer is dynamic, involving continuous competitive adsorption and desorption, and that coverage need not be complete to work. A layer covering only 35 percent of a close-packed monolayer produced 90 to 100 percent blocking efficiency on a hydrophobic surface and 68 to 100 percent on a hydrophilic one.

When is adding BSA the wrong choice?

Any time the added protein would interfere with the readout. Mass spectrometry, protein quantitation and single-molecule imaging all suffer when a large excess of albumin enters the sample, and published guidance notes there is still no consensus on the best carrier molecule or its optimum concentration. In those settings researchers reach for alternatives: low-bind tubes with co-polymer surfaces, organic solvent additives, non-interfering competitor proteins chosen so they do not co-elute with the analyte, lipid vesicles, or covalent polymer coatings such as PEG.

What This Means for Handling Research Peptides

Adsorption to the vessel is a systematic, quantifiable error rather than background noise, and it is largest exactly where researchers work hardest — at low concentration, in small volumes, across multiple transfers. Recovery figures spanning 18 percent to 96 percent for the same material in different tubes should retire the assumption that a container is inert.

The remedy is a set of small, cheap decisions rather than one product: choose the container material against the sequence's charge and hydrophobicity, keep stocks concentrated and dilute late, minimise transfers, and add a blocking agent when the assay can tolerate one. Bovine serum albumin remains the most widely used of those agents, with limits that are well characterised rather than hidden. For related chemistry, our articles on peptide hydrophobicity and freeze-thaw stability cover the other two variables that most often explain a sample that isn't behaving.

For research use only. Not for human or animal consumption of any kind. The information in this article is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. The statements made have not been evaluated by the U.S. Food and Drug Administration. These products are NOT FDA APPROVED. Please consult with a licensed healthcare professional before making any decisions regarding your health or research.

Optides LLC is a chemical supplier. Optides LLC is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Optides LLC is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act.